Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Gains from Investment Securities (2019 - 2024)

Capricor Therapeutics has reported Gains from Investment Securities over the past 8 years, most recently at -$305501.0 for Q4 2024.

  • For Q4 2024, Gains from Investment Securities fell 10645.43% year-over-year to -$305501.0; the TTM value through Dec 2025 reached -$272183.0, changed 0.0%, while the annual FY2025 figure was $13.4 million, 22259.55% up from the prior year.
  • Gains from Investment Securities for Q4 2024 was -$305501.0 at Capricor Therapeutics, down from $458869.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $10.6 million in Q2 2024 and troughed at -$305501.0 in Q4 2024.
  • A 5-year average of $2.1 million and a median of $1.8 million in 2020 define the central range for Gains from Investment Securities.
  • On a YoY basis, Gains from Investment Securities climbed as much as 483.45% in 2024 and fell as far as 10645.43% in 2024.
  • Year by year, Gains from Investment Securities stood at $1.8 million in 2020, then crashed by 97.15% to $51044.0 in 2021, then skyrocketed by 5076.4% to $2.6 million in 2022, then crashed by 99.89% to $2897.0 in 2023, then plummeted by 10645.43% to -$305501.0 in 2024.
  • Business Quant data shows Gains from Investment Securities for CAPR at -$305501.0 in Q4 2024, $458869.0 in Q3 2024, and $10.6 million in Q2 2024.